MedPath

Osteopathic Manipulative Treatment for Gastro-oesophageal Reflux Disease

Phase 2
Recruiting
Conditions
Gastro-oesophageal Reflux Disease
Interventions
Other: Osteopathic manipulative treatment (OMT)
Registration Number
NCT06317675
Lead Sponsor
Studio Osteopatico Busto Arsizio
Brief Summary

To evaluate the effects of osteopathic manipulative treatment in patients affected by symptoms related to gastro-oesophageal reflux disease (GERD)

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Retrosternal burning sensation and/or regurgitation
  • Diagnosis of reflux with any methodology
  • Duration of symptoms for more than 3 months
  • Taking short or long-term proton pump inhibitors (as needed, treatment start date and expected end date, mg, drug name)
  • With or without esophagitis
  • With or without hiatal hernia
  • With or without helicobacter pylori
  • GERDQ questionnaire > 8 points
Exclusion Criteria
  • neoplastic pathologies
  • patients who have undergone surgery for GERD
  • systemic pathologies (rheumatic, infectious conditions, feverish state, vascular alterations, endocrine diseases including diabetes, metabolic and neoplastic syndromes),
  • patients already undergoing manipulative therapy for reflux
  • patients with active gastric ulcers
  • congenital or acquired immune diseases
  • allergic state of any kind
  • pregnancy
  • use of intrauterine device
  • patients undergoing corticosteroid therapy
  • patients already subjected to manual/respiratory therapy in the last 3 months

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
OMT + breathing exercises.Osteopathic manipulative treatment (OMT)This group will receive OMTs and five breathing exercises to perform daily at home. A recorded video of the exercises will be provided to participants in this group.
Osteopathic manipulative treatment (OMT)Osteopathic manipulative treatment (OMT)Participants will receive four OMTs at week 1, 2, 4 and 8. Joint mobilization techniques for ribs, cervical and dorsal spine, as well as visceral treatment, soft-tissue release on diaphragm and abdominal wall will be used.
Primary Outcome Measures
NameTimeMethod
Mean change in GERD-HRQLAt week 2, 4 an 8.

best possible score: 0, worst possible score: 50

Adverse effectsAt week 2, 4 and through study completion (8 weeks)

Type and number.

Secondary Outcome Measures
NameTimeMethod
Exercise adherencethrough study completion (8 weeks)

number of exercises per day performed by participants in OMT + exercise group.

Change in drugs useAt week 2, 4 and 8.

Types, number and frequency of drug assumptions (such as PPI and other oral suspensions)

Trial Locations

Locations (1)

CTFO

🇮🇹

Saronno, Varese, Italy

© Copyright 2025. All Rights Reserved by MedPath